News & Events

AstraZeneca’s BioVentureHub is planning to double in size. That’s according to Matti Ahlqvist, Site Director for AstraZeneca’s R&D facility in Mölndal, in LIFe-time’s special edition focused on Sweden’s competitiveness in life science. The BioVentureHub is one of several major investments in West Sweden that are attracting attention.

“The customer should be as satisfied with a research product as with a laptop or phone,” says CELLINK’s CEO, Erik Gatenholm, who is one of the speakers at TEDx Gothenburg with the theme ‘disrupting status quo’.

Large parts of the Swedish life science industry join forces to deliver an appeal with sharp proposals to the Swedish government. The message is that there is no longer time to wait if Sweden is to stand up in increasing international competition. The goal is double export until 2030.

The ambition level is super high for the newly-inaugurated AI INNOVATION of Sweden. The Swedish Minister for Energy and Digital Development, Anders Ygeman, sees the connection to Sweden’s Vision e-Health 2025 and the opportunities for healthtech.

Innovation in life science must more than ever be based on healthcare needs and demands. Then, great opportunities can be created for the business and industry. This is one of the starting points in a new industry-wide collaboration project in Västra Götaland.

The development plans for Sahlgrenska Life will completely change the cityscape around the Sahlgrenska University Hospital and Sahlgrenska Science Park. In a 3D visualisation you can now see for yourself the extent of the planned construction.

Healthtech and sustainability belong together. This is the basic idea for the project “The World’s Most Sustainable Healthcare 2030,” in which Sahlgrenska Science Park is collaborating with Swecare, Medeon, Medicon Village and Nordic Center for Sustainable Healthcare.

Two markets stood out when the students at the School of Economics, Business and Law in Gothenburg analysed four customer segments for startup companies within healthtech. But the increasingly important networks have no limits.

PledPharma’s first patient in Japan is worth SEK 49 million. And through its establishment at Sahlgrenska Science Park, the company wants to gain access to the expertise available in the Gothenburg region.

Drones take the fastest route carrying new blood to patients in need. Sahlgrenska Science Park company, Everdrone, shows how healthtech is quickly changing healthcare and life science.

China has come a long way in the transition from production to innovation. This made an impression on Marianne Dicander Alexandersson, Chairman of the Board of Sahlgrenska Science Park, during her trip to Asia with the Royal Technology Mission (RTM).

Sahlgrenska University Hospital is now launching an internet treatment for insomnia, which has been developed via the digital psychiatry unit (ePsykiatrin) in Gothenburg. It is the first internet-based treatment to be widely introduced in the hospital and it is an example of how healthtech can contribute to care becoming both more accessible and more cost-effective. And, in this case, also a tool to counter mental illness.